Artemis Health
Anticipating that NGS will become a key clinical tool in coming years, several proteomics firms and researchers are investigating it as a platform for protein biomarker detection assays that use nucleotides as capture agents, hoping to take advantage of the technology's precision and multiplexing ability.
In Brief This Week: Fluidigm; Artemis Health; Pacific Biomarkers
In Brief This Week is a Friday column containing news items that our readers may have missed during the week.
Using a sequencing method and proprietary algorithm based on technology licensed from Stephen Quake at Stanford University, the researchers correctly identified all trisomy 21 and trisomy 18 cases.
Caren Mason
Bioethicist Urges Discussion, Preparation for Fetal Genetic Tests
A bioethicist argues that it is now time to start taking steps to consider how to handle ethical, social, and legal issues that loom over non-invasive prenatal genetic tests.